Bruce Peacock's Net Worth
$1.67 Million
Who is Bruce Peacock?
Bruce Peacock has an estimated net worth of $1.67 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, PHARMACOPEIA INC, NeurogesX Inc, LIGAND PHARMACEUTICALS INC, OCULAR THERAPEUTIX, INC, Ophthotech Corp., WINDTREE THERAPEUTICS INC /DE/, APPLIED GENETIC TECHNOLOGIES CORP, Ocean Power Technologies, Inc., and ADOLOR CORP.
SEC CIK
Bruce Peacock's CIK is 0001228459
Past Insider Trading and Trends
2014 was Bruce Peacock's most active year for acquiring shares with 13 total transactions. Bruce Peacock's most active month to acquire stocks was the month of May. 2014 was Bruce Peacock's most active year for disposing of shares, totalling 23 transactions. Bruce Peacock's most active month to dispose stocks was the month of May. 2020 saw Bruce Peacock paying a total of $152,555.00 for 50,000 shares, this is the most they've acquired in one year. In 2014 Bruce Peacock cashed out on 102,100 shares for a total of $1,920,327.37, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Dicerna Pharmaceuticals Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PHARMACOPEIA INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
NeurogesX Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
LIGAND PHARMACEUTICALS INC (LGND) Snapshot price: $74.72
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
OCULAR THERAPEUTIX, INC (OCUL) Snapshot price: $4.99
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
$5.09 | $127,180.00 |
0
|
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |